6388-47-2Relevant articles and documents
POLY-ADP RIBOSE POLYMERASE (PARP) INHIBITORS
-
Page/Page column 27, (2018/07/29)
The present invention is related to a pharmaceutical composition comprising a pharmaceutically acceptable carrier or diluent and a compound represented by the following structural formula: The present invention is also related a method of treating a subject with a disease which can be ameliorated by inhibition of poly(ADP-ribose)polymerase (PARP). The definitions of the variables are provided herein.
Extending the biocatalytic scope of regiocomplementary flavin-dependent halogenase enzymes
Shepherd, Sarah A.,Karthikeyan, Chinnan,Latham, Jonathan,Struck, Anna-Winona,Thompson, Mark L.,Menon, Binuraj R. K.,Styles, Matthew Q.,Levy, Colin,Leys, David,Micklefield, Jason
, p. 3454 - 3460 (2015/05/27)
Flavin-dependent halogenases are potentially valuable biocatalysts for the regioselective halogenation of aromatic compounds. These enzymes, utilising benign inorganic halides, offer potential advantages over traditional non-enzymatic halogenation chemistry that often lacks regiocontrol and requires deleterious reagents. Here we extend the biocatalytic repertoire of the tryptophan halogenases, demonstrating how these enzymes can halogenate a range of alternative aryl substrates. Using structure guided mutagenesis we also show that it is possible to alter the regioselectivity as well as increase the activity of the halogenases with non-native substrates including anthranilic acid; an important intermediate in the synthesis and biosynthesis of pharmaceuticals and other valuable products. This journal is
METHOD FOR PRODUCING NITROBENZENE COMPOUND
-
Paragraph 0180, (2014/06/24)
A method for producing a nitrobenzene compound represented by general formula (2), wherein R1 and R5 are the same or different, and each is a halogen atom or another functional group, and R2, R3, and R4 are the same or different, and each is a hydrogen atom or another functional group, comprises oxidizing an aniline compound represented by general formula (1), wherein R1, R2, R3, R4, and R5 are the same as described above, with hydrogen peroxide in the presence of a tungsten compound under an acidic condition, followed by oxidation with hydrogen peroxide under a neutral to alkaline condition.